New Approaches in Pharmacogenomics
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Pharmacogenetics".
Deadline for manuscript submissions: 20 January 2026 | Viewed by 1793
Special Issue Editor
Interests: genetic polymorphisms; functional genomics; adverse drug reactions; pharmacogenomics; personalized medicine; drug metabolism;
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Inter-individual variability in drug responses is common and is likely to become increasingly problematic as the elderly population requiring multiple medications grows. The causes of this inter-individual variability mainly include genomic factors. Fortunately, analytical techniques have improved in recent years, so the need to incorporate pharmacogenomics into clinical practice is now recognized in many countries around the world. To reduce inter-individual variability in drug responses and increase drug efficacy and safety, we need to modify the drugs, the routes of administration, and the doses we use. However, despite this need, there is currently a huge knowledge gap in pharmacogenomics among healthcare practitioners, which poses the major dilemma of how incorporate pharmacogenomics into the healthcare system. Therefore, this Special Issue aims to collect efforts and findings on the application of currently developed or revealed pharmacogenomic knowledge and technologies to clinical practice in order to bridge this gap and overcome the dilemma.
Cutting-edge research in pharmacogenomics can create guidelines that can be personalized and applied to humans by verifying the results through prospective clinical trials, clinical cases, and functional genomics.
Suitable topics include drug- and disease-specific pharmacogenomic testing methods, user-friendly decision support tools/software for personalized medicine, collaborative data between genomic experts and healthcare providers, biomarkers for predicting treatment outcomes, innovative treatment approaches based on pharmacogenomics, innovative medical education programs/experiences, and research on integrating pharmacogenomics into clinical practice. In addition, authors are encouraged to submit novel findings on the biological function of genetic variants and their association with disease. Suitable papers include original research, reviews, and updated overviews of pharmacogenetics and pharmacogenomics.
Dr. Su-Jun Lee
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- personalized medicine
- supporting tools/software for personalized medicine
- pharmacogenomic test
- pharmacogenomic education
- drug response
- genomic biomarker
- functional genomics
- healthcare system
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
